• Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead Realasset Realasset
moneycontrol.com
Houseviews: 4 stocks to buy before the weekend
  • 
	IRB

	Brokerage: Citi

	Rating: Buy

	Target: Rs 238

	Rationale: The management has said it does not see any impact of the recent events on its business or bid for projects. While the business fundamentals remain unchanged, the news flow around this issue could remain a near-term overhang on the stock.

    IRB Brokerage: Citi Rating: Buy Target: Rs 238 Rationale: The management has said it does not see any impact of the recent events on its business or bid for projects. While the business fundamentals remain unchanged, the news flow around this issue could remain a near-term overhang on the stock.

  • 
	Exide

	Brokerage: Merrill Lynch

	Rating: Buy

	Target: Rs 144

	Rationale: Earnings disappointed due to a weaker EBITDA margin lead by high cost inventory and price discounts. They have reduced their FY14 EPS estimate by 12%.

    Exide Brokerage: Merrill Lynch Rating: Buy Target: Rs 144 Rationale: Earnings disappointed due to a weaker EBITDA margin lead by high cost inventory and price discounts. They have reduced their FY14 EPS estimate by 12%.

  • 
	Cipla

	Brokerage: CLSA

	Rating: Outperform

	Target: Rs 360

	Rationale: They believe Cipla is likely to deliver a strong operating performance in the coming quarter particularly on Lexapro supplies to Teva and a weakening currency. 

    Cipla Brokerage: CLSA Rating: Outperform Target: Rs 360 Rationale: They believe Cipla is likely to deliver a strong operating performance in the coming quarter particularly on Lexapro supplies to Teva and a weakening currency. 

  • 
	Marico

	Brokerage: Standard Chartered

	Rating: Outperform

	Target: Rs 203

	Rationale: Strong volume lad sales growth was a positive in Marico’s financial performance in the fourth quarter. Despite a sharp increase in ad spends the company has posted a strong 37% growth in EBITDA and remains our top pick.

    Marico Brokerage: Standard Chartered Rating: Outperform Target: Rs 203 Rationale: Strong volume lad sales growth was a positive in Marico’s financial performance in the fourth quarter. Despite a sharp increase in ad spends the company has posted a strong 37% growth in EBITDA and remains our top pick.

  • 
	IRB

	Brokerage: Citi

	Rating: Buy

	Target: Rs 238

	Rationale: The management has said it does not see any impact of the recent events on its business or bid for projects. While the business fundamentals remain unchanged, the news flow around this issue could remain a near-term overhang on the stock.
  • 
	Exide

	Brokerage: Merrill Lynch

	Rating: Buy

	Target: Rs 144

	Rationale: Earnings disappointed due to a weaker EBITDA margin lead by high cost inventory and price discounts. They have reduced their FY14 EPS estimate by 12%.
  • 
	Cipla

	Brokerage: CLSA

	Rating: Outperform

	Target: Rs 360

	Rationale: They believe Cipla is likely to deliver a strong operating performance in the coming quarter particularly on Lexapro supplies to Teva and a weakening currency. 
  • 
	Marico

	Brokerage: Standard Chartered

	Rating: Outperform

	Target: Rs 203

	Rationale: Strong volume lad sales growth was a positive in Marico’s financial performance in the fourth quarter. Despite a sharp increase in ad spends the company has posted a strong 37% growth in EBITDA and remains our top pick.

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login